Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Acquisitions & Divestments came in at $1.0 million in Q1 2026, down 75.0% year-on-year from $4.0 million in Q1 2025, and down 50.0% quarter-over-quarter from $2.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Acquisitions & Divestments across 18 years of filings, most recently posting $1.0 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $1.0 million, down 75.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 58.33% YoY), and the FY2025 annual result was $8.0 million, down 42.86% from the prior year.
- Change in Acquisitions & Divestments came in at $1.0 million for Q1 2026 at Bausch Health Companies, down from $2.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $13.0 million in Q4 2023 to a low of -$2.0 million in Q2 2023.
- The 5-year median for Change in Acquisitions & Divestments is $4.0 million (2023), against an average of $4.2 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 550.0% in 2023, while the deepest fall reached 128.57% in 2023.
- Bausch Health Companies' Change in Acquisitions & Divestments stood at $2.0 million in 2022, then soared by 550.0% to $13.0 million in 2023, then slumped by 76.92% to $3.0 million in 2024, then plunged by 33.33% to $2.0 million in 2025, then slumped by 50.0% to $1.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $1.0 million (Q1 2026), $2.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Dec 31, 2023 | 13.00 Mn |